{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:39:25Z","timestamp":1793651965584,"version":"4.5.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:00:00Z","timestamp":1423785600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12896-015-0121-4","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T08:10:14Z","timestamp":1423728614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A novel adenoviral vector carrying an all-in-one Tet-On system with an autoregulatory loop for tight, inducible transgene expression"],"prefix":"10.1186","volume":"15","author":[{"given":"Hao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiting","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinwen","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,13]]},"reference":[{"key":"121_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1073\/pnas.0811426106","volume":"106","author":"BW Carey","year":"2009","unstructured":"Carey BW, Markoulaki S, Hanna J, Saha K, Gao Q, Mitalipova M, et al. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A. 2009;106:157\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"121_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.addr.2008.12.016","volume":"61","author":"K Stieger","year":"2009","unstructured":"Stieger K, Belbellaa B, Le Guiner C, Moullier P, Rolling F. In vivo gene regulation using tetracycline-regulatable systems. Adv Drug Deliv Rev. 2009;61:527\u201341.","journal-title":"Adv Drug Deliv Rev"},{"key":"121_CR3","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.2353\/ajpath.2010.091146","volume":"177","author":"D Veron","year":"2010","unstructured":"Veron D, Reidy K, Marlier A, Bertuccio C, Villegas G, Jimenez J, et al. Induction of podocyte VEGF164 overexpression at different stages of development causes congenital nephrosis or steroid-resistant nephrotic syndrome. Am J Pathol. 2010;177:2225\u201333.","journal-title":"Am J Pathol"},{"key":"121_CR4","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1128\/JB.181.21.6585-6590.1999","volume":"181","author":"Y Ji","year":"1999","unstructured":"Ji Y, Marra A, Rosenberg M, Woodnutt G. Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aureus infection. J Bacteriol. 1999;181:6585\u201390.","journal-title":"J Bacteriol"},{"key":"121_CR5","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1093\/nar\/gnf134","volume":"30","author":"K Sch\u00f6nig","year":"2002","unstructured":"Sch\u00f6nig K, Schwenk F, Rajewsky K, Bujard H. Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res. 2002;30:e134.","journal-title":"Nucleic Acids Res"},{"key":"121_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/jgm.384","volume":"5","author":"UJ Tietge","year":"2003","unstructured":"Tietge UJ, Kozarsky KF, Donahee MH, Rader DJ. A tetracycline-regulated adenoviral expression system for in vivo delivery of transgenes to lung and liver. J Gene Med. 2003;5:567\u201375.","journal-title":"J Gene Med"},{"key":"121_CR7","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1073\/pnas.89.12.5547","volume":"89","author":"M Gossen","year":"1992","unstructured":"Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A. 1992;89:5547\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"121_CR8","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1126\/science.7792603","volume":"268","author":"M Gossen","year":"1995","unstructured":"Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 1995;268:1766\u20139.","journal-title":"Science"},{"key":"121_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0014-5793(02)02587-5","volume":"517","author":"MR K\u00e4mper","year":"2002","unstructured":"K\u00e4mper MR, Gohla G, Schl\u00fcter G. A novel positive tetracycline-dependent transactivator (rtTA) variant with reduced background activity and enhanced activation potential. FEBS Lett. 2002;517:115\u201320.","journal-title":"FEBS Lett"},{"key":"121_CR10","doi-asserted-by":"publisher","first-page":"7963","DOI":"10.1073\/pnas.130192197","volume":"97","author":"S Urlinger","year":"2000","unstructured":"Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A. 2000;97:7963\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"121_CR11","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1093\/nar\/25.14.2723","volume":"25","author":"U Baron","year":"1997","unstructured":"Baron U, Gossen M, Bujard H. Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res. 1997;25:2723\u20139.","journal-title":"Nucleic Acids Res"},{"key":"121_CR12","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/nar\/27.2.708","volume":"27","author":"K Forster","year":"1999","unstructured":"Forster K, Helbl V, Lederer T, Urlinger S, Wittenburg N, Hillen W. Tetracycline-inducible expression systems with reduced basal activity in mammalian cells. Nucleic Acids Res. 1999;27:708\u201310.","journal-title":"Nucleic Acids Res"},{"key":"121_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/(SICI)1521-2254(199901\/02)1:1<4::AID-JGM4>3.0.CO;2-Y","volume":"1","author":"S Freundlieb","year":"1999","unstructured":"Freundlieb S, Schirra-Muller C, Bujard H. A tetracycline controlled activation\/repression system with increased potential for gene transfer into mammalian cells. J Gene Med. 1999;1:4\u201312.","journal-title":"J Gene Med"},{"key":"121_CR14","doi-asserted-by":"publisher","first-page":"25222","DOI":"10.1074\/jbc.M101512200","volume":"276","author":"Z Zhu","year":"2001","unstructured":"Zhu Z, Ma B, Homer RJ, Zheng T, Elias JA. Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J Biol Chem. 2001;276:25222\u20139.","journal-title":"J Biol Chem"},{"key":"121_CR15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1089\/104303403767740803","volume":"14","author":"H Mizuguchi","year":"2003","unstructured":"Mizuguchi H, Xu ZL, Sakurai F, Mayumi T, Hayakawa T. Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions. Hum Gene Ther. 2003;14:1265\u201377.","journal-title":"Hum Gene Ther"},{"key":"121_CR16","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/sj.gt.3301813","volume":"9","author":"V Salucci","year":"2002","unstructured":"Salucci V, Scarito A, Aurisicchio L, Lamartina S, Nicolaus G, Giampaoli S, et al. Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2(s)-M2 tetracycline transactivator and repressor system. Gene Ther. 2002;9:1415\u201321.","journal-title":"Gene Ther"},{"key":"121_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/90242","volume":"19","author":"H Xia","year":"2001","unstructured":"Xia H, Mao Q, Davidson BL. The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors. Nat Biotechnol. 2001;19:640\u20134.","journal-title":"Nat Biotechnol"},{"key":"121_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1172\/JCI6926","volume":"104","author":"A Ashkenazi","year":"1999","unstructured":"Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest. 1999;104:155\u201362.","journal-title":"J Clin Invest"},{"key":"121_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/5517","volume":"5","author":"H Walczak","year":"1999","unstructured":"Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med. 1999;5:157\u201363.","journal-title":"Nat Med"},{"key":"121_CR20","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/sj.onc.1205151","volume":"21","author":"A Nesterov","year":"2002","unstructured":"Nesterov A, Ivashchenko Y, Kraft AS. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells. Oncogene. 2002;21:1135\u201340.","journal-title":"Oncogene"},{"key":"121_CR21","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.4049\/jimmunol.170.2.1027","volume":"170","author":"SA Renshaw","year":"2003","unstructured":"Renshaw SA, Parmar JS, Singleton V, Rowe SJ, Dockrell DH, Dower SK, et al. Acceleration of human neutrophil apoptosis by TRAIL. J Immunol. 2003;170:1027\u201333.","journal-title":"J Immunol"},{"key":"121_CR22","first-page":"553","volume":"60","author":"M Leverkus","year":"2000","unstructured":"Leverkus M, Neumann M, Mengling T, Rauch CT, Br\u00f6cker EB, Krammer PH, et al. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res. 2000;60:553\u20139.","journal-title":"Cancer Res"},{"key":"121_CR23","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0140-6736(00)02659-3","volume":"356","author":"R Nitsch","year":"2000","unstructured":"Nitsch R, Bechmann I, Deisz RA, Haas D, Lehmann TN, Wendling U, et al. Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Lancet. 2000;356:827\u20138.","journal-title":"Lancet"},{"key":"121_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/carcin\/bgp298","volume":"31","author":"JY Kim","year":"2010","unstructured":"Kim JY, Kim EH, Kim SU, Kwon TK, Choi KS. Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation. Carcinogenesis. 2010;31:367\u201375.","journal-title":"Carcinogenesis"},{"key":"121_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/sj.onc.1207025","volume":"23","author":"EH Kim","year":"2004","unstructured":"Kim EH, Kim SU, Shin DY, Choi KS. Roscovitine sensitizes glioma cells to TRAIL-mediated apoptosis by downregulation of survivin and XIAP. Oncogene. 2004;23:446\u201356.","journal-title":"Oncogene"},{"key":"121_CR26","doi-asserted-by":"publisher","first-page":"8274","DOI":"10.1158\/0008-5472.CAN-07-0407","volume":"67","author":"YG Son","year":"2007","unstructured":"Son YG, Kim EH, Kim JY, Kim SU, Kwon TK, Yoon AR, et al. Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin. Cancer Res. 2007;67:8274\u201384.","journal-title":"Cancer Res"},{"key":"121_CR27","doi-asserted-by":"publisher","first-page":"11498","DOI":"10.1074\/jbc.M109.090209","volume":"285","author":"B Sung","year":"2010","unstructured":"Sung B, Park B, Yadav VR, Aggarwal BB. Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors. J Biol Chem. 2010;285:11498\u2013507.","journal-title":"J Biol Chem"},{"key":"121_CR28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3858\/emm.2011.43.3.016","volume":"43","author":"MH Moon","year":"2011","unstructured":"Moon MH, Jeong JK, Seo JS, Seol JW, Lee YJ, Xue M, et al. Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation. Exp Mol Med. 2011;43:138\u201345.","journal-title":"Exp Mol Med"},{"key":"121_CR29","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nature03556","volume":"435","author":"FD Urnov","year":"2005","unstructured":"Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S, et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature. 2005;435:646\u201351.","journal-title":"Nature"},{"key":"121_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nature11537","volume":"491","author":"VM Bedell","year":"2012","unstructured":"Bedell VM, Wang Y, Campbell JM, Poshusta TL, Starker CG, Krug 2nd RG, et al. In vivo genome editing using a high-efficiency TALEN system. Nature. 2012;491:114\u20138.","journal-title":"Nature"},{"key":"121_CR31","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339:823\u20136.","journal-title":"Science"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12896-015-0121-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-015-0121-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-015-0121-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-015-0121-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T08:36:58Z","timestamp":1630571818000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/s12896-015-0121-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,13]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["121"],"URL":"https:\/\/doi.org\/10.1186\/s12896-015-0121-4","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,13]]},"assertion":[{"value":"27 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}